or Try an Advanced Search...

    Muscle Diseases Stocks List

    Symbol Grade Name % Change
    REGN B Regeneron Pharmaceuticals, Inc. 2.07
    DYN D Dyne Therapeutics, Inc. 0.31
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Muscle Disease Angiogenesis Antibodies Asthma Atopic Dermatitis Biopharmaceutical Biotechnology Bone Breakthrough Therapy Cardiovascular Disease Cartilage Cholesterol Clinical Development Clinical Research Colorectal Cancer Dermatitis Disease Disorders Duchenne Duchenne Muscular Dystrophy

    Related ETFs - A few ETFs which own one or more of the above listed Muscle Diseases stocks.

    Symbol Grade Name Weight
    IBB C iShares Nasdaq Biotechnology Index Fund 8.35
    IBBQ C Invesco Nasdaq Biotechnology ETF 8.14
    BBH B Market Vectors Biotech ETF 7.81
    BIB C ProShares Ultra Nasdaq Biotechnology 5.79
    PJP A PowerShares Dynamic Pharmaceuticals 5.57
    View all Muscle Diseases ETFs...
    Compare ETFs
    Compare IBB to BIB Compare IBBQ to BIB Compare IBBQ to PJP

        Muscle Diseases Stocks Recent News

        Date Stock Title
        May 5 REGN Wall Street Breakfast: The Week Ahead
        May 3 REGN Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
        May 3 REGN Regeneron Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
        May 3 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
        May 3 DYN Dyne Therapeutics GAAP EPS of -$0.81 misses by $0.01
        May 3 REGN Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
        May 2 DYN Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
        May 2 REGN Regeneron Pharmaceuticals, Inc. (REGN) Q1 2024 Earnings Call Transcript
        May 2 REGN Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
        May 2 REGN Regeneron (REGN) Reports Q1 Earnings: What Key Metrics Have to Say
        May 2 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
        May 2 REGN Regeneron Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 REGN Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
        May 2 REGN Regeneron falls after Q1 miss; announces $3B share buybacks
        May 2 REGN 3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
        May 2 REGN Regeneron Earnings Miss; Biotech Giant's Stock Falls
        May 2 REGN Regeneron Pharmaceuticals misses top-line and bottom-line estimates; updates FY24 outlook
        May 2 REGN Regeneron Reports First Quarter 2024 Financial and Operating Results
        May 1 REGN Regeneron Pharmaceuticals Q1 2024 Earnings Preview
        May 1 REGN Roche’s VABYSMO has successful Q1 sales despite Regeneron and Bayer’s EYLEA HD launch
        Related Industries: Biotechnology
        Related Stock Lists: Muscle Disease Angiogenesis Antibodies Asthma Atopic Dermatitis Biopharmaceutical Biotechnology Bone Breakthrough Therapy Cardiovascular Disease Cartilage Cholesterol Clinical Development Clinical Research Colorectal Cancer Dermatitis Disease Disorders Duchenne Duchenne Muscular Dystrophy
        Muscle Diseases

        Muscle diseases are conditions that affect the body's muscles. These diseases can cause weakness, pain, and stiffness in the muscles, as well as problems with movement. Some muscle diseases are caused by genetic mutations, while others are caused by lifestyle factors such as poor nutrition or lack of exercise. Treatment for muscle diseases may include physical therapy, medications, and lifestyle changes.

        Browse All Tags